Filing Details

Accession Number:
0001491877-11-000007
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-03-15 13:00:00
Reporting Period:
2011-03-11
Filing Date:
2011-03-15
Accepted Time:
2011-03-15 18:31:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
72444 Nabi Biopharmaceuticals NABI Biological Products, (No Disgnostic Substances) (2836) 591212264
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1376960 Jason Aryeh 34 Summer Rd.
Greenwich CT 06831
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-03-11 9,900 $5.74 154,883 No 4 S Indirect Indirect
Common Stock Disposition 2011-03-11 9,900 $5.75 144,983 No 4 S Indirect Indirect
Common Stock Disposition 2011-03-11 4,900 $5.80 140,083 No 4 S Indirect Indirect
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Indirect
No 4 S Indirect Indirect
No 4 S Indirect Indirect
Footnotes
  1. The sales reported in this Form 4 were of shares beneficially owned by Jason Aryeh through JALAA Equities, LP.
  2. Consists of shares benefically owned by Jason Aryeh through his relationship with JALAA Equities, LP, the Jason Aryeh Trust, the Jason Aryeh 2003 Family Trust, and the Jason Aryeh IRA (collectively, the "Aryeh Entities"). Mr. Aryeh disclaims beneficial ownership of all securities held through the Aryeh Entities, except to the extent of any indirect pecuniary interest he may have therein.